group_id,Component_1,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_08842,5.432910715704306,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_07351,4.962188237227038,FUN_033759-T1,Peve_00009253,Pocillopora_meandrina_HIv1___RNAseq.g28744.t1,three_way,61.443,FUN_033759-T1,Q28005,LSHR_BOVIN,,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Bos taurus (Bovine),36.1,498.0,3.2000000000000003e-80,301.6,sp|Q28005|LSHR_BOVIN Lutropin-choriogonadotropic hormone receptor OS=Bos taurus OX=9913 GN=LHCGR PE=2 SV=1,GO:0001541; GO:0004964; GO:0005886; GO:0007189; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_06522,4.960228263835266,FUN_029339-T1,Peve_00023361,Pocillopora_meandrina_HIv1___RNAseq.g17301.t1,three_way,61.434333333333335,FUN_029339-T1,Q01973,ROR1_HUMAN,,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",Homo sapiens (Human),31.6,773.0,1.1000000000000001e-118,429.1,sp|Q01973|ROR1_HUMAN Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens OX=9606 GN=ROR1 PE=1 SV=2,GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0015026; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092,astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0006355; GO:0016740; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_07441,4.736609692178185,FUN_033933-T1,Peve_00020980,Pocillopora_meandrina_HIv1___RNAseq.g26583.t1,three_way,86.51866666666666,FUN_033933-T1,Q15915,ZIC1_HUMAN,,Zinc finger protein ZIC 1 (Zinc finger protein 201) (Zinc finger protein of the cerebellum 1),Homo sapiens (Human),37.8,249.0,1.7e-36,155.2,sp|Q15915|ZIC1_HUMAN Zinc finger protein ZIC 1 OS=Homo sapiens OX=9606 GN=ZIC1 PE=1 SV=2,GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007389; GO:0007417; GO:0007420; GO:0007628; GO:0008270; GO:0008589; GO:0010467; GO:0021510; GO:0021766; GO:0021772; GO:0030154; GO:0042307; GO:0042472; GO:0045893; GO:0098727; GO:1990837,adult walking behavior [GO:0007628]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; inner ear morphogenesis [GO:0042472]; maintenance of cell number [GO:0098727]; olfactory bulb development [GO:0021772]; pattern specification process [GO:0007389]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_01210,4.574972456781309,FUN_004887-T1,Peve_00005850,Pocillopora_meandrina_HIv1___RNAseq.g10661.t1,three_way,61.143166666666666,FUN_004887-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),31.4,1097.0,1.9e-124,450.7,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09806,4.460039846973009,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_01740,4.442664170468085,FUN_007062-T1,Peve_00025326,Pocillopora_meandrina_HIv1___RNAseq.g20109.t1,three_way,70.79983333333334,FUN_007062-T1,Q8IX03,KIBRA_HUMAN,,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),Homo sapiens (Human),29.0,1136.0,8.3e-51,204.1,sp|Q8IX03|KIBRA_HUMAN Protein KIBRA OS=Homo sapiens OX=9606 GN=WWC1 PE=1 SV=1,GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0035329; GO:0035330; GO:0035331; GO:0035591; GO:0043410; GO:0046621; GO:0048471; GO:0060090,cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587],kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0007163; GO:0043226; GO:0048870; GO:0060090; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_04041,4.409937539941139,FUN_016350-T1,Peve_00004331,Pocillopora_meandrina_HIv1___RNAseq.16312_t,three_way,70.639,FUN_016350-T1,Q90WR8,SP3_CHICK,,Transcription factor Sp3,Gallus gallus (Chicken),48.7,117.0,7.9e-20,100.1,sp|Q90WR8|SP3_CHICK Transcription factor Sp3 OS=Gallus gallus OX=9031 GN=SP3 PE=1 SV=1,GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001779; GO:0001889; GO:0002318; GO:0003682; GO:0005829; GO:0006357; GO:0008270; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0043353; GO:0045944; GO:0048596; GO:0048706; GO:0060216; GO:0061629,B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; myeloid progenitor cell differentiation [GO:0002318]; natural killer cell differentiation [GO:0001779]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217],cytosol [GO:0005829]; PML body [GO:0016605]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_01656,4.201335675041037,FUN_006826-T1,Peve_00023770,Pocillopora_meandrina_HIv1___RNAseq.g20475.t1,three_way,76.18166666666667,,,,,,,,,,,,,,,,,
OG_03911,4.081927346429522,FUN_015990-T1,Peve_00023998,Pocillopora_meandrina_HIv1___RNAseq.g21387.t1,three_way,69.50233333333334,FUN_015990-T1,Q5BIM1,,,,,25.3,490.0,3.2e-30,135.2,sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1,,,,,,
OG_07052,4.062062731258986,FUN_032274-T1,Peve_00011763,Pocillopora_meandrina_HIv1___RNAseq.g24974.t1,three_way,68.399,FUN_032274-T1,A8E7N9,,,,,31.6,370.0,2.9e-44,181.0,sp|A8E7N9|GDF6B_DANRE Growth/differentiation factor 6-B OS=Danio rerio OX=7955 GN=gdf6b PE=2 SV=1,,,,,,
OG_07861,4.022245223251443,FUN_035216-T2,Peve_00035892,Pocillopora_meandrina_HIv1___RNAseq.g27615.t1,three_way,70.04816666666666,FUN_035216-T2,Q503Z8,IRX6A_DANRE,,Iroquois homeobox protein 6a,Danio rerio (Zebrafish) (Brachydanio rerio),47.6,233.0,1.9e-40,168.3,sp|Q503Z8|IRX6A_DANRE Iroquois homeobox protein 6a OS=Danio rerio OX=7955 GN=irx6a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030182; GO:0048468,cell development [GO:0048468]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_01630,3.9161146944185616,FUN_006744-T1,Peve_00039581,Pocillopora_meandrina_HIv1___RNAseq.g20530.t1,three_way,63.90916666666666,FUN_006744-T1,Q8BNA6,FAT3_MOUSE,,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Mus musculus (Mouse),33.8,4122.0,0.0,2094.3,sp|Q8BNA6|FAT3_MOUSE Protocadherin Fat 3 OS=Mus musculus OX=10090 GN=Fat3 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:1904936; GO:2000171,cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],dendrite [GO:0030425]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0048856; GO:0048870,plasma membrane; cell adhesion; anatomical structure development; cell motility
OG_03906,3.9070977623373,FUN_015982-T1,Peve_00024012,Pocillopora_meandrina_HIv1___RNAseq.g21404.t2,three_way,57.955,FUN_015982-T1,Q00174,LAMA_DROME,,Laminin subunit alpha (Laminin A chain),Drosophila melanogaster (Fruit fly),29.8,729.0,2.6e-88,330.1,sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2,GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711,"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]",axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021],extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048856; GO:0098542,immune system process; structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism
OG_07865,3.8575155086553625,FUN_035222-T1,Peve_00035887,Pocillopora_meandrina_HIv1___RNAseq.g27609.t1,three_way,55.40566666666666,FUN_035222-T1,Q501V0,KPSH1_DANRE,,Serine/threonine-protein kinase H1 homolog (EC 2.7.11.1),Danio rerio (Zebrafish) (Brachydanio rerio),66.9,323.0,4.8e-116,419.9,sp|Q501V0|KPSH1_DANRE Serine/threonine-protein kinase H1 homolog OS=Danio rerio OX=7955 GN=pskh1 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005737; GO:0106310,,cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04737,3.855280889420623,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_01608,3.821707115403465,FUN_006652-T1,Peve_00029039,Pocillopora_meandrina_HIv1___RNAseq.g19955.t1,three_way,64.58433333333333,FUN_006652-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),32.4,1666.0,2.3000000000000004e-224,781.6,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_01728,3.777569123668643,FUN_007020-T1,Peve_00037180,Pocillopora_meandrina_HIv1___RNAseq.g20542.t1,three_way,63.67233333333333,FUN_007020-T1,Q6ZZY0,,,,,46.9,497.0,1.3e-139,499.6,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_01287,3.764299466679231,FUN_005108-T1,Peve_00007468,Pocillopora_meandrina_HIv1___RNAseq.g8270.t1,three_way,63.20066666666666,FUN_005108-T1,Q96B86,,,,,35.5,361.0,3.8e-52,207.2,sp|Q96B86|RGMA_HUMAN Repulsive guidance molecule A OS=Homo sapiens OX=9606 GN=RGMA PE=1 SV=4,,,,,,
OG_04615,3.721938021375033,FUN_022314-T1,Peve_00021691,Pocillopora_meandrina_HIv1___TS.g22047.t1,three_way,61.79866666666667,,,,,,,,,,,,,,,,,
OG_01437,3.719740561987689,FUN_005873-T1,Peve_00015756,Pocillopora_meandrina_HIv1___RNAseq.g19664.t1,three_way,58.21833333333333,,,,,,,,,,,,,,,,,
OG_08396,3.696213565099339,FUN_037010-T1,Peve_00032338,Pocillopora_meandrina_HIv1___RNAseq.g26698.t1,three_way,85.58966666666667,FUN_037010-T1,Q8N2G6,,,,,56.0,234.0,5.3e-63,242.7,sp|Q8N2G6|ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 OS=Homo sapiens OX=9606 GN=ZCCHC24 PE=1 SV=1,,,,,,
OG_00308,3.6952982128631713,FUN_001110-T1,Peve_00029335,Pocillopora_meandrina_HIv1___RNAseq.g29363.t1,three_way,71.534,FUN_001110-T1,P15384,,,,,49.9,407.0,2.3e-84,314.7,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_04006,3.690763719417803,FUN_016305-T1,Peve_00032293,Pocillopora_meandrina_HIv1___RNAseq.g10040.t1,three_way,94.53566666666669,FUN_016305-T1,Q6NZ04,SIX1B_DANRE,,Homeobox protein six1b (Homeobox protein six1a) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,285.0,6.9e-92,338.6,sp|Q6NZ04|SIX1B_DANRE Homeobox protein six1b OS=Danio rerio OX=7955 GN=six1b PE=1 SV=1,GO:0000978; GO:0000981; GO:0002074; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0014857; GO:0021984; GO:0043282; GO:0048741; GO:0048839; GO:0048935; GO:0051146,adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; chordate pharyngeal muscle development [GO:0043282]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; peripheral nervous system neuron development [GO:0048935]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146],cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06152,3.689967193338089,FUN_027984-T2,Peve_00011299,Pocillopora_meandrina_HIv1___RNAseq.g13864.t1,three_way,75.97583333333333,,,,,,,,,,,,,,,,,
OG_09609,3.6895369576226114,FUN_041767-T1,Peve_00041572,Pocillopora_meandrina_HIv1___RNAseq.g15244.t1,three_way,57.924,FUN_041767-T1,Q6WRH9,,,,,29.6,406.0,5.6000000000000005e-28,128.6,sp|Q6WRH9|IGS10_RAT Immunoglobulin superfamily member 10 OS=Rattus norvegicus OX=10116 GN=Igsf10 PE=1 SV=1,,,,,,
OG_01489,3.6022446646431576,FUN_006165-T1,Peve_00023607,Pocillopora_meandrina_HIv1___RNAseq.g20426.t1,three_way,60.60533333333333,FUN_006165-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),33.7,5014.0,0.0,2299.2,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_02090,3.5643344227734315,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_07103,3.548450931501201,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_08704,3.539911439962775,FUN_037953-T1,Peve_00040733,Pocillopora_meandrina_HIv1___RNAseq.g26512.t1,three_way,50.168,FUN_037953-T1,Q91905,,,,,68.3,60.0,4.7e-18,92.8,sp|Q91905|FXI1B_XENLA Forkhead box protein I1-B OS=Xenopus laevis OX=8355 GN=foxi1-b PE=2 SV=1,,,,,,
OG_10139,3.526922134485046,FUN_043526-T1,Peve_00011962,Pocillopora_meandrina_HIv1___RNAseq.g8034.t1,three_way,58.651,FUN_043526-T1,Q9NY43,,,,,44.1,118.0,1.7e-15,84.3,sp|Q9NY43|BARH2_HUMAN BarH-like 2 homeobox protein OS=Homo sapiens OX=9606 GN=BARHL2 PE=1 SV=2,,,,,,
OG_05256,3.5249353528223573,FUN_023759-T1,Peve_00044461,Pocillopora_meandrina_HIv1___RNAseq.g3497.t1,three_way,51.79566666666666,FUN_023759-T1,E7FBY6,AGRA2_DANRE,,Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124),Danio rerio (Zebrafish) (Brachydanio rerio),26.0,889.0,4.7e-66,255.4,sp|E7FBY6|AGRA2_DANRE Adhesion G protein-coupled receptor A2 OS=Danio rerio OX=7955 GN=adgra2 PE=1 SV=2,GO:0001525; GO:0004930; GO:0005886; GO:0007399; GO:0060070; GO:1990909,angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; nervous system development [GO:0007399],plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0048856; GO:0060089,plasma membrane; anatomical structure development; molecular transducer activity
OG_06556,3.522258006934968,FUN_029438-T1,Peve_00028188,Pocillopora_meandrina_HIv1___RNAseq.g17152.t1,three_way,76.8055,FUN_029438-T1,Q8IZF0,NALCN_HUMAN,,Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1),Homo sapiens (Human),41.8,1604.0,0.0,1137.9,sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1,GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805,"calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]",monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_07716,3.52065220066754,FUN_034870-T1,Peve_00005769,Pocillopora_meandrina_HIv1___RNAseq.g27159.t1,three_way,54.551,FUN_034870-T1,Q91Y77,,,,,29.8,423.0,2.3e-49,198.7,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_05437,3.513526611093134,FUN_024390-T2,Peve_00018042,Pocillopora_meandrina_HIv1___RNAseq.g18621.t1,three_way,74.62266666666667,FUN_024390-T2,Q80VL3,,,,,50.8,413.0,3e-126,454.1,sp|Q80VL3|PRIC3_MOUSE Prickle planar cell polarity protein 3 OS=Mus musculus OX=10090 GN=Prickle3 PE=1 SV=1,,,,,,
OG_00386,3.5101783734999064,FUN_001238-T1,Peve_00002842,Pocillopora_meandrina_HIv1___RNAseq.g2515.t2,three_way,45.375,FUN_001238-T1,Q8IVU1,,,,,32.5,517.0,1.1e-67,260.4,sp|Q8IVU1|IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 OS=Homo sapiens OX=9606 GN=IGDCC3 PE=1 SV=2,,,,,,
OG_07349,3.4970599313259023,FUN_033756-T1,Peve_00004915,Pocillopora_meandrina_HIv1___RNAseq.g28747.t1,three_way,85.5945,FUN_033756-T1,Q13136,LIPA1_HUMAN,,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),Homo sapiens (Human),45.4,1218.0,1.3e-187,658.7,sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1,GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077,cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444],,GO:0005829; GO:0007010; GO:0007155; GO:0034330; GO:0043226,cytosol; cytoskeleton organization; cell adhesion; cell junction organization; organelle
OG_01002,3.478742678068545,FUN_004421-T1,Peve_00026932,Pocillopora_meandrina_HIv1___RNAseq.g16665.t1,three_way,58.136,FUN_004421-T1,F1NWE3,,,,,29.1,1542.0,2.5e-170,601.7,sp|F1NWE3|PTPRS_CHICK Receptor-type tyrosine-protein phosphatase S OS=Gallus gallus OX=9031 GN=PTPRS PE=1 SV=3,,,,,,
OG_04195,3.4419670125041257,FUN_016720-T1,Peve_00014673,Pocillopora_meandrina_HIv1___RNAseq.g230.t1,three_way,61.32066666666666,FUN_016720-T1,Q64729,TGFR1_MOUSE,,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),Mus musculus (Mouse),38.4,487.0,5.7e-74,280.0,sp|Q64729|TGFR1_MOUSE TGF-beta receptor type-1 OS=Mus musculus OX=10090 GN=Tgfbr1 PE=1 SV=1,GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001935; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0005929; GO:0006915; GO:0007179; GO:0007507; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0016020; GO:0030199; GO:0030307; GO:0030335; GO:0030336; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0035556; GO:0036446; GO:0042118; GO:0043065; GO:0043066; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046847; GO:0046872; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0050431; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060391; GO:0060395; GO:0060412; GO:0060978; GO:0060982; GO:0061450; GO:0070021; GO:0070411; GO:0070723; GO:0071560; GO:1901203; GO:1902462; GO:1904018; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237,activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; cilium [GO:0005929]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021],"ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005929; GO:0006355; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; nucleoplasm; endosome; plasma membrane; cilium; regulation of DNA-templated transcription; programmed cell death; transferase activity; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_01261,3.4417281880510804,FUN_005023-T1,Peve_00028649,Pocillopora_meandrina_HIv1___RNAseq.g8329.t1,three_way,83.2865,FUN_005023-T1,A2BEA6,,,,,62.1,195.0,1.3e-58,228.8,sp|A2BEA6|ARI3A_DANRE AT-rich interactive domain-containing protein 3A OS=Danio rerio OX=7955 GN=arid3a PE=1 SV=1,,,,,,
OG_00679,3.432336161140119,FUN_002102-T1,Peve_00004294,Pocillopora_meandrina_HIv1___RNAseq.g1737.t1,three_way,59.12716666666666,FUN_002102-T1,P18461,,,,,37.9,833.0,3.8e-141,503.8,sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus OX=9031 GN=FGFR2 PE=2 SV=1,,,,,,
OG_01475,3.4248866536869467,FUN_006038-T1,Peve_00023433,Pocillopora_meandrina_HIv1___RNAseq.g20251.t1,three_way,65.71133333333333,FUN_006038-T1,Q7T2C4,S26A5_DANRE,,Prestin (Solute carrier family 26 member 5),Danio rerio (Zebrafish) (Brachydanio rerio),37.0,686.0,1.8e-115,418.3,sp|Q7T2C4|S26A5_DANRE Prestin OS=Danio rerio OX=7955 GN=slc26a5 PE=2 SV=1,GO:0005737; GO:0005886; GO:0006821; GO:0008271; GO:0015075; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0016020; GO:0019531; GO:0019532; GO:0042391; GO:0160044; GO:0160046; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; oxalate transport [GO:0019532]; regulation of membrane potential [GO:0042391]; sulfate transmembrane transport [GO:1902358],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; formate transmembrane transporter activity [GO:0015499]; monoatomic ion transmembrane transporter activity [GO:0015075]; oxalate transmembrane transporter activity [GO:0019531]; oxalate:chloride antiporter activity [GO:0160046]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01407,3.416690956624865,FUN_005476-T1,Peve_00041489,Pocillopora_meandrina_HIv1___RNAseq.g6630.t1,three_way,45.82566666666667,,,,,,,,,,,,,,,,,
OG_07340,3.4086239832052345,FUN_033745-T1,Peve_00004929,Pocillopora_meandrina_HIv1___RNAseq.g28757.t1,three_way,54.01,FUN_033745-T1,Q8QGQ6,CLOCK_CHICK,,Circadian locomoter output cycles protein kaput,Gallus gallus (Chicken),37.6,367.0,2.7000000000000002e-58,228.0,sp|Q8QGQ6|CLOCK_CHICK Circadian locomoter output cycles protein kaput OS=Gallus gallus OX=9031 GN=CLOCK PE=1 SV=2,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005829; GO:0006357; GO:0006473; GO:0006974; GO:0032922; GO:0046983; GO:0051775; GO:0070888; GO:1990513,circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; protein acetylation [GO:0006473]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775],CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_08856,3.406649972430537,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_08594,3.39738711203685,FUN_037709-T1,Peve_00027437,Pocillopora_meandrina_HIv1___RNAseq.g1402.t1,three_way,58.09033333333333,FUN_037709-T1,E7F1U2,DNMBP_DANRE,,Dynamin-binding protein (Scaffold protein Tuba),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,728.0,7.8e-103,377.5,sp|E7F1U2|DNMBP_DANRE Dynamin-binding protein OS=Danio rerio OX=7955 GN=dnmbp PE=2 SV=1,GO:0001822; GO:0005085; GO:0005737; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793,cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005794; GO:0005856; GO:0043226; GO:0044782; GO:0048856; GO:0098772,Golgi apparatus; cytoskeleton; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_05841,3.386261163894517,FUN_025889-T1,Peve_00024284,Pocillopora_meandrina_HIv1___RNAseq.g10542.t1,three_way,53.60116666666666,FUN_025889-T1,Q5ZM41,,,,,29.0,728.0,7.4e-64,247.3,sp|Q5ZM41|TEX10_CHICK Testis-expressed protein 10 homolog OS=Gallus gallus OX=9031 GN=TEX10 PE=2 SV=1,,,,,,
OG_02949,3.3654884388238924,FUN_012067-T1,Peve_00004104,Pocillopora_meandrina_HIv1___RNAseq.g23636.t1,three_way,67.023,FUN_012067-T1,Q7Z020,,,,,28.6,553.0,9.3e-45,184.1,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_05551,3.364392353755281,FUN_024758-T1,Peve_00027326,Pocillopora_meandrina_HIv1___RNAseq.g18826.t1,three_way,87.74933333333333,,,,,,,,,,,,,,,,,
OG_00081,3.3643364234427304,FUN_000409-T1,Peve_00033505,Pocillopora_meandrina_HIv1___RNAseq.g2517.t1,three_way,55.74733333333334,FUN_000409-T1,Q6A044,,,,,26.9,312.0,9.8e-18,93.2,sp|Q6A044|EREP2_MOUSE Protein ENTREP2 OS=Mus musculus OX=10090 GN=Entrep2 PE=2 SV=3,,,,,,
OG_00843,3.3532021521651125,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_07066,3.3343551937799325,FUN_032299-T1,Peve_00020128,Pocillopora_meandrina_HIv1___RNAseq.g24900.t1,three_way,50.632333333333335,FUN_032299-T1,Q3ZT31,SNX25_MOUSE,,Sorting nexin-25,Mus musculus (Mouse),27.2,125.0,1.3e-07,60.8,sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3,GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091,negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801],endosome [GO:0005768]; endosome membrane [GO:0010008],phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005768; GO:0008289; GO:0031410; GO:0043226,endosome; lipid binding; cytoplasmic vesicle; organelle
OG_08520,3.3097772935637617,FUN_037452-T1,Peve_00044119,Pocillopora_meandrina_HIv1___RNAseq.g1368.t1,three_way,59.91483333333333,FUN_037452-T1,Q9IA95,,,,,32.7,266.0,2.4e-45,184.1,sp|Q9IA95|SFRP3_CHICK Secreted frizzled-related protein 3 OS=Gallus gallus OX=9031 GN=FRZB PE=2 SV=1,,,,,,
OG_08928,3.26778060441053,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_05951,3.260160719191358,FUN_026211-T1,Peve_00044665,Pocillopora_meandrina_HIv1___RNAseq.g3049.t1,three_way,49.01616666666666,FUN_026211-T1,A2AX52,CO6A4_MOUSE,,Collagen alpha-4(VI) chain,Mus musculus (Mouse),24.8,1256.0,9.1e-63,246.1,sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2,GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991],collagen binding [GO:0005518],GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_08482,3.2560054219990064,FUN_037313-T1,Peve_00006178,Pocillopora_meandrina_HIv1___RNAseq.g10707.t1,three_way,74.689,FUN_037313-T1,Q32PP9,,,,,66.0,94.0,6.7e-27,122.5,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_07762,3.252144931623582,FUN_034956-T1,Peve_00036680,Pocillopora_meandrina_HIv1___RNAseq.g27836.t1,three_way,74.127,FUN_034956-T1,P39949,CCNE1_RAT,,G1/S-specific cyclin-E1,Rattus norvegicus (Rat),51.8,311.0,1.5e-85,318.2,sp|P39949|CCNE1_RAT G1/S-specific cyclin-E1 OS=Rattus norvegicus OX=10116 GN=Ccne1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0001547; GO:0001889; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0006270; GO:0007129; GO:0009410; GO:0014074; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0031100; GO:0031670; GO:0032355; GO:0032570; GO:0032880; GO:0033197; GO:0034097; GO:0044877; GO:0045471; GO:0045597; GO:0048545; GO:0051301; GO:0051412; GO:0051597; GO:0051726; GO:0070192; GO:0097134; GO:1900087; GO:1902462,animal organ regeneration [GO:0031100]; antral ovarian follicle growth [GO:0001547]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to progesterone [GO:0032570]; response to purine-containing compound [GO:0014074]; response to steroid hormone [GO:0048545]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016740; GO:0022414; GO:0032200; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; transferase activity; reproductive process; telomere organization; organelle; anatomical structure development; molecular function regulator activity
OG_03779,3.232353539208295,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_08299,3.2300710066090903,FUN_036248-T1,Peve_00045282,Pocillopora_meandrina_HIv1___TS.g14942.t1,three_way,59.625,,,,,,,,,,,,,,,,,
OG_01121,3.2300193192286226,FUN_004684-T1,Peve_00035122,Pocillopora_meandrina_HIv1___RNAseq.g8765.t1,three_way,65.35983333333333,FUN_004684-T1,Q07008,NOTC1_RAT,,Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Rattus norvegicus (Rat),42.2,628.0,7.7e-77,291.2,sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3,GO:0000122; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006915; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008283; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685],"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003677; GO:0005634; GO:0005783; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006954; GO:0012501; GO:0016192; GO:0022414; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; nucleus; endoplasmic reticulum; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; inflammatory response; programmed cell death; vesicle-mediated transport; reproductive process; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular transducer activity; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_06310,3.2299693747869065,FUN_028549-T1,Peve_00000746,Pocillopora_meandrina_HIv1___RNAseq.g6218.t1,three_way,56.03633333333333,FUN_028549-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),30.5,285.0,4.8e-29,131.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_00729,3.228098898882729,FUN_002695-T1,Peve_00009946,Pocillopora_meandrina_HIv1___RNAseq.g20725.t1,three_way,61.78816666666667,FUN_002695-T1,Q90VV1,HES4B_XENLA,,Transcription factor HES-4-B (Hairy and enhancer of split 4-B) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2b),Xenopus laevis (African clawed frog),37.6,194.0,7.2e-20,99.0,sp|Q90VV1|HES4B_XENLA Transcription factor HES-4-B OS=Xenopus laevis OX=8355 GN=hes4-b PE=1 SV=1,GO:0000122; GO:0000978; GO:0002088; GO:0005634; GO:0007219; GO:0007517; GO:0014029; GO:0021501; GO:0033504; GO:0043066; GO:0043565; GO:0045892; GO:0046982; GO:0048642; GO:0050767,floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; prechordal plate formation [GO:0021501]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development
OG_07956,3.2251000159364764,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_00252,3.222768187484144,FUN_001016-T1,Peve_00041043,Pocillopora_meandrina_HIv1___RNAseq.g29160.t1,three_way,48.55133333333333,FUN_001016-T1,Q0IHU9,,,,,42.9,203.0,7.6e-44,180.6,sp|Q0IHU9|PRUN2_XENTR Protein prune homolog 2 OS=Xenopus tropicalis OX=8364 GN=Prune2 PE=2 SV=1,,,,,,
OG_00732,3.219626369784518,FUN_002698-T1,Peve_00034497,Pocillopora_meandrina_HIv1___RNAseq.g20728.t1,three_way,72.25633333333333,FUN_002698-T1,Q6IRB2,HES1A_XENLA,,Transcription factor HES-1-A (Hairy and enhancer of split 1-A) (Protein hairy-1) (Xhairy-1) (Xhairy1) (Xlh1),Xenopus laevis (African clawed frog),39.2,245.0,2.4e-26,120.6,sp|Q6IRB2|HES1A_XENLA Transcription factor HES-1-A OS=Xenopus laevis OX=8355 GN=hes1-a PE=1 SV=1,GO:0000122; GO:0000978; GO:0005634; GO:0007219; GO:0043425; GO:0043565; GO:0045665; GO:0045892; GO:0046982; GO:0048635; GO:0050767,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],bHLH transcription factor binding [GO:0043425]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_09562,3.218339505210392,FUN_041672-T1,Peve_00007760,Pocillopora_meandrina_HIv1___RNAseq.g14001.t1,three_way,59.1795,,,,,,,,,,,,,,,,,
OG_04338,3.1945489109218204,FUN_017952-T1,Peve_00001586,Pocillopora_meandrina_HIv1___RNAseq.g224.t1,three_way,96.399,FUN_017952-T1,Q7T1R4,,,,,91.5,117.0,8.8e-61,235.3,sp|Q7T1R4|FOXA2_XENTR Forkhead box protein A2 OS=Xenopus tropicalis OX=8364 GN=foxa2 PE=2 SV=1,,,,,,
OG_03864,3.193962139953981,FUN_015372-T1,Peve_00000220,Pocillopora_meandrina_HIv1___RNAseq.g21694.t1,three_way,63.956,FUN_015372-T1,Q9H6I2,SOX17_HUMAN,,Transcription factor SOX-17,Homo sapiens (Human),47.8,178.0,6.5e-29,129.8,sp|Q9H6I2|SOX17_HUMAN Transcription factor SOX-17 OS=Homo sapiens OX=9606 GN=SOX17 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001570; GO:0001656; GO:0001706; GO:0001714; GO:0001828; GO:0001947; GO:0003142; GO:0003143; GO:0003151; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007283; GO:0007493; GO:0007507; GO:0008013; GO:0010467; GO:0010628; GO:0016055; GO:0021903; GO:0023019; GO:0030308; GO:0031648; GO:0035050; GO:0042074; GO:0043279; GO:0045732; GO:0045893; GO:0045944; GO:0045995; GO:0048617; GO:0048866; GO:0050821; GO:0060214; GO:0060913; GO:0060914; GO:0060956; GO:0061009; GO:0061010; GO:0061031; GO:0061629; GO:0072091; GO:0072189; GO:0090090; GO:1903226; GO:1990830; GO:2000035; GO:2000043; GO:2000738,angiogenesis [GO:0001525]; cardiac cell fate determination [GO:0060913]; cardiogenic plate morphogenesis [GO:0003142]; cell migration involved in gastrulation [GO:0042074]; cellular response to leukemia inhibitory factor [GO:1990830]; common bile duct development [GO:0061009]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cell differentiation [GO:0060956]; endocardium formation [GO:0060214]; endoderm formation [GO:0001706]; endodermal cell fate determination [GO:0007493]; endodermal cell fate specification [GO:0001714]; endodermal digestive tract morphogenesis [GO:0061031]; gallbladder development [GO:0061010]; gene expression [GO:0010467]; heart development [GO:0007507]; heart formation [GO:0060914]; heart looping [GO:0001947]; inner cell mass cellular morphogenesis [GO:0001828]; metanephros development [GO:0001656]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; outflow tract morphogenesis [GO:0003151]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of cardiac cell fate specification [GO:2000043]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of stem cell division [GO:2000035]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; rostrocaudal neural tube patterning [GO:0021903]; signal transduction involved in regulation of gene expression [GO:0023019]; spermatogenesis [GO:0007283]; stem cell fate specification [GO:0048866]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_06188,3.1879371546125927,FUN_028103-T1,Peve_00032588,Pocillopora_meandrina_HIv1___RNAseq.g15573.t1,three_way,47.289,,,,,,,,,,,,,,,,,
OG_10121,3.169163477596001,FUN_043499-T1,Peve_00024907,Pocillopora_meandrina_HIv1___RNAseq.g7964.t1,three_way,56.86333333333334,FUN_043499-T1,P82279,CRUM1_HUMAN,,Protein crumbs homolog 1,Homo sapiens (Human),23.8,741.0,3.6e-48,196.4,sp|P82279|CRUM1_HUMAN Protein crumbs homolog 1 OS=Homo sapiens OX=9606 GN=CRB1 PE=1 SV=2,GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0008104; GO:0010001; GO:0010467; GO:0010842; GO:0016324; GO:0032991; GO:0035003; GO:0035845; GO:0042462; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0071482; GO:0097386,blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; protein localization [GO:0008104]; retina layer formation [GO:0010842],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003],calcium ion binding [GO:0005509],GO:0005576; GO:0005886; GO:0007155; GO:0007163; GO:0023052; GO:0030154; GO:0048856; GO:0061024,extracellular region; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; signaling; cell differentiation; anatomical structure development; membrane organization
OG_05572,3.149108487357428,FUN_024815-T1,Peve_00026076,Pocillopora_meandrina_HIv1___RNAseq.g18772.t1,three_way,69.34433333333334,FUN_024815-T1,Q96PE2,ARHGH_HUMAN,,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),Homo sapiens (Human),40.1,1066.0,9.2e-179,630.2,sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056,actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0007010; GO:0098772,cytosol; cytoskeleton organization; molecular function regulator activity
OG_00588,3.13008058364141,FUN_001671-T2,Peve_00038393,Pocillopora_meandrina_HIv1___RNAseq.g29390.t1,three_way,54.833666666666666,FUN_001671-T2,O60293,,,,,28.7,1468.0,5.8000000000000005e-133,478.0,sp|O60293|ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein OS=Homo sapiens OX=9606 GN=ZFC3H1 PE=1 SV=3,,,,,,
OG_09336,3.1280031044306296,FUN_040299-T1,Peve_00038649,Pocillopora_meandrina_HIv1___TS.g20792.t1,three_way,42.627833333333335,FUN_040299-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),24.5,4769.0,0.0,1096.6,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_03209,3.1272551504231108,FUN_012701-T1,Peve_00016835,Pocillopora_meandrina_HIv1___RNAseq.g12828.t1,three_way,66.00966666666667,,,,,,,,,,,,,,,,,
OG_08907,3.115795782098893,FUN_038338-T1,Peve_00000098,Pocillopora_meandrina_HIv1___RNAseq.g1110.t1,three_way,67.40100000000001,,,,,,,,,,,,,,,,,
OG_06110,3.1147491206083173,FUN_027815-T1,Peve_00036487,Pocillopora_meandrina_HIv1___RNAseq.g13889.t2,three_way,90.976,FUN_027815-T1,Q23356,MIG15_CAEEL,,Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15),Caenorhabditis elegans,44.9,1094.0,1.7e-240,833.9,sp|Q23356|MIG15_CAEEL Serine/threonine-protein kinase mig-15 OS=Caenorhabditis elegans OX=6239 GN=mig-15 PE=2 SV=3,GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0022414; GO:0030334; GO:0032228; GO:0033563; GO:0043408; GO:0048812; GO:0106310,"body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of MAPK cascade [GO:0043408]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproductive process [GO:0022414]",cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_02741,3.1145700083683137,FUN_011284-T1,Peve_00033625,Pocillopora_meandrina_HIv1___RNAseq.g22145.t2,three_way,53.47266666666667,FUN_011284-T1,Q5M775,CYTSB_HUMAN,,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),Homo sapiens (Human),46.2,106.0,1.9e-21,106.3,sp|Q5M775|CYTSB_HUMAN Cytospin-B OS=Homo sapiens OX=9606 GN=SPECC1 PE=1 SV=1,GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177,actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824],apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0048856; GO:0050877,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; organelle; anatomical structure development; nervous system process
OG_05649,3.1026158168316247,FUN_025372-T1,Peve_00040522,Pocillopora_meandrina_HIv1___RNAseq.g13329.t1,three_way,85.562,FUN_025372-T1,Q92997,DVL3_HUMAN,,Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3),Homo sapiens (Human),61.0,485.0,3.2e-124,447.2,sp|Q92997|DVL3_HUMAN Segment polarity protein dishevelled homolog DVL-3 OS=Homo sapiens OX=9606 GN=DVL3 PE=1 SV=2,GO:0000785; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0009410; GO:0031267; GO:0032880; GO:0032956; GO:0035556; GO:0035567; GO:0043547; GO:0045893; GO:0045944; GO:0046330; GO:0050821; GO:0060070; GO:0060071; GO:0150012,"canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein localization [GO:0032880]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",chromatin [GO:0000785]; cytosol [GO:0005829],beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267],GO:0005829; GO:0006355,cytosol; regulation of DNA-templated transcription
OG_09591,3.1024796488931803,FUN_041734-T1,Peve_00024444,Pocillopora_meandrina_HIv1___RNAseq.6485_t,three_way,58.46866666666666,FUN_041734-T1,Q7Z7M0,MEGF8_HUMAN,,Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4),Homo sapiens (Human),33.1,2861.0,0.0,1367.4,sp|Q7Z7M0|MEGF8_HUMAN Multiple epidermal growth factor-like domains protein 8 OS=Homo sapiens OX=9606 GN=MEGF8 PE=1 SV=2,GO:0000151; GO:0003143; GO:0005509; GO:0005634; GO:0007224; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0070062; GO:0071907; GO:0097094; GO:0097155; GO:1990403,aorta development [GO:0035904]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224],extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],calcium ion binding [GO:0005509],GO:0005634; GO:0043226; GO:0048856; GO:0048870; GO:0065003,nucleus; organelle; anatomical structure development; cell motility; protein-containing complex assembly
OG_06124,3.1020853360696585,FUN_027902-T1,Peve_00020105,Pocillopora_meandrina_HIv1___RNAseq.g13882.t1,three_way,48.062,,,,,,,,,,,,,,,,,
OG_03764,3.095135222507645,FUN_015089-T1,Peve_00010705,Pocillopora_meandrina_HIv1___RNAseq.g21187.t1,three_way,72.56533333333334,FUN_015089-T1,Q71F56,MD13L_HUMAN,,Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like),Homo sapiens (Human),29.0,2382.0,7.899999999999999e-204,713.4,sp|Q71F56|MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens OX=9606 GN=MED13L PE=1 SV=1,GO:0003713; GO:0005654; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592]; nucleoplasm [GO:0005654],transcription coactivator activity [GO:0003713],GO:0005654; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_06717,3.0937640669211484,FUN_031467-T1,Peve_00026558,Pocillopora_meandrina_HIv1___RNAseq.g5084.t2,three_way,78.09566666666667,FUN_031467-T1,Q5RDQ2,PALS1_PONAB,,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),46.4,576.0,2.3e-140,501.5,sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1,GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204,central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204],ATP binding [GO:0005524],GO:0005794; GO:0043226; GO:0048856,Golgi apparatus; organelle; anatomical structure development
OG_06197,3.087007380230219,FUN_028122-T1,Peve_00004261,Pocillopora_meandrina_HIv1___RNAseq.g15557.t2,three_way,43.58133333333333,FUN_028122-T1,P36335,,,,,26.3,598.0,1.3e-35,152.9,sp|P36335|NCA12_XENLA Neural cell adhesion molecule 1-B OS=Xenopus laevis OX=8355 GN=ncam1-b PE=2 SV=1,,,,,,
OG_02537,3.080300625250222,FUN_010620-T1,Peve_00031460,Pocillopora_meandrina_HIv1___TS.g26115.t1,three_way,50.77283333333333,FUN_010620-T1,O14514,AGRB1_HUMAN,,Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)],Homo sapiens (Human),29.6,659.0,1.9999999999999999e-63,246.9,sp|O14514|AGRB1_HUMAN Adhesion G protein-coupled receptor B1 OS=Homo sapiens OX=9606 GN=ADGRB1 PE=1 SV=2,GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016020; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]",cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786],GO:0002376; GO:0005615; GO:0005886; GO:0007155; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0060089; GO:0061024; GO:0098542,immune system process; extracellular space; plasma membrane; cell adhesion; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; molecular transducer activity; membrane organization; defense response to other organism
OG_01709,3.079904825420281,FUN_006982-T1,Peve_00045260,Pocillopora_meandrina_HIv1___TS.g29608.t2b,three_way,78.57366666666667,FUN_006982-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),44.9,187.0,1.9e-40,167.5,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_05011,3.076370767585236,FUN_023163-T1,Peve_00018795,Pocillopora_meandrina_HIv1___TS.g25340.t2c,three_way,74.67866666666667,FUN_023163-T1,Q8K4G5,ABLM1_MOUSE,,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1),Mus musculus (Mouse),48.6,253.0,8.9e-78,292.0,sp|Q8K4G5|ABLM1_MOUSE Actin-binding LIM protein 1 OS=Mus musculus OX=10090 GN=Ablim1 PE=1 SV=1,GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0060271,axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725],actin binding [GO:0003779]; metal ion binding [GO:0046872],GO:0005856; GO:0006351; GO:0006355; GO:0007010; GO:0008092; GO:0043226; GO:0044782,cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_05881,3.074211419408475,FUN_026034-T1,Peve_00022184,Pocillopora_meandrina_HIv1___RNAseq.g10547.t1,three_way,87.94766666666666,FUN_026034-T1,P29074,PTN4_HUMAN,,Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1),Homo sapiens (Human),43.1,929.0,2e-217,757.3,sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1,GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254,protein dephosphorylation [GO:0006470],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05445,3.0723966038344126,FUN_024401-T1,Peve_00033232,Pocillopora_meandrina_HIv1___RNAseq.g18633.t1,three_way,75.52233333333334,FUN_024401-T1,P20595,GCYB1_RAT,,Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit),Rattus norvegicus (Rat),46.0,620.0,2.1e-138,494.6,sp|P20595|GCYB1_RAT Guanylate cyclase soluble subunit beta-1 OS=Rattus norvegicus OX=10116 GN=Gucy1b1 PE=1 SV=2,GO:0004383; GO:0005525; GO:0005829; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0032991; GO:0038060; GO:0044877; GO:0046872; GO:0051879; GO:0070026; GO:0070482; GO:0071732; GO:0098831; GO:0098978,cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482],"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone cytoplasmic component [GO:0098831]; protein-containing complex [GO:0032991]",GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005829; GO:0009975; GO:0016829; GO:0055086; GO:1901135,catalytic activity; cytosol; cyclase activity; lyase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04039,3.0692537261093595,FUN_016347-T1,Peve_00004355,Pocillopora_meandrina_HIv1___RNAseq.g9679.t1,three_way,82.813,FUN_016347-T1,Q9JHX2,,,,,31.5,321.0,1.9e-18,95.1,sp|Q9JHX2|SP5_MOUSE Transcription factor Sp5 OS=Mus musculus OX=10090 GN=Sp5 PE=2 SV=1,,,,,,
OG_06118,3.065027925866798,FUN_027849-T2,Peve_00024334,Pocillopora_meandrina_HIv1___RNAseq.g13871.t1,three_way,64.28016666666666,FUN_027849-T2,Q9QZS7,,,,,24.7,522.0,3.9e-26,122.5,sp|Q9QZS7|NPHN_MOUSE Nephrin OS=Mus musculus OX=10090 GN=Nphs1 PE=1 SV=2,,,,,,
OG_07628,3.062689901085234,FUN_034376-T1,Peve_00027168,Pocillopora_meandrina_HIv1___RNAseq.g26154.t1,three_way,68.84483333333333,FUN_034376-T1,E7FAG6,AMR1A_DANRE,,Activating molecule in BECN1-regulated autophagy protein 1A,Danio rerio (Zebrafish) (Brachydanio rerio),26.3,954.0,1.9e-61,238.8,sp|E7FAG6|AMR1A_DANRE Activating molecule in BECN1-regulated autophagy protein 1A OS=Danio rerio OX=7955 GN=ambra1a PE=2 SV=2,GO:0000045; GO:0000209; GO:0000423; GO:0005634; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0006914; GO:0007626; GO:0008406; GO:0031410; GO:0043009; GO:0043231; GO:0045591; GO:0048741; GO:0072542; GO:0080008; GO:1901526; GO:1904544; GO:1990756; GO:2000045,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; chordate embryonic development [GO:0043009]; gonad development [GO:0008406]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; skeletal muscle fiber development [GO:0048741],autophagosome [GO:0005776]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634],protein phosphatase activator activity [GO:0072542]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0005856; GO:0006914; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; mitochondrion; vacuole; endoplasmic reticulum; cytosol; cytoskeleton; autophagy; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_04054,3.060128448778575,FUN_016373-T1,Peve_00022923,Pocillopora_meandrina_HIv1___RNAseq.g9745.t1,three_way,73.565,FUN_016373-T1,P42587,,,,,58.7,75.0,4.2e-17,89.7,sp|P42587|HNK2_XENLA Homeobox protein XENK-2 OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_04582,3.0559819581929117,FUN_022245-T1,Peve_00037428,Pocillopora_meandrina_HIv1___RNAseq.g4760.t1,three_way,54.247166666666665,FUN_022245-T1,Q96DN6,MBD6_HUMAN,,Methyl-CpG-binding domain protein 6 (Methyl-CpG-binding protein MBD6),Homo sapiens (Human),41.4,99.0,6.5e-16,88.6,sp|Q96DN6|MBD6_HUMAN Methyl-CpG-binding domain protein 6 OS=Homo sapiens OX=9606 GN=MBD6 PE=1 SV=2,GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0010369,,chromocenter [GO:0010369]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005654; GO:0005694; GO:0043226,nucleus; nucleoplasm; chromosome; organelle
OG_08639,3.041375255357594,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05274,3.032956557949672,FUN_023928-T1,Peve_00026565,Pocillopora_meandrina_HIv1___TS.g27906.t1a,three_way,36.54933333333333,FUN_023928-T1,Q3V2Q8,N42L1_MOUSE,,NEDD4-binding protein 2-like 1,Mus musculus (Mouse),51.4,175.0,3.6999999999999997e-41,172.2,sp|Q3V2Q8|N42L1_MOUSE NEDD4-binding protein 2-like 1 OS=Mus musculus OX=10090 GN=N4bp2l1 PE=1 SV=1,,,,,,
OG_06702,3.0269708737508267,FUN_031269-T1,Peve_00036737,Pocillopora_meandrina_HIv1___TS.g23896.t1,three_way,69.62383333333334,FUN_031269-T1,Q3T906,GNPTA_HUMAN,,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta],Homo sapiens (Human),39.7,1334.0,1e-257,891.7,sp|Q3T906|GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens OX=9606 GN=GNPTAB PE=1 SV=1,GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0033299; GO:0046835,carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976],GO:0003824; GO:0005794; GO:0005975; GO:0007040; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; carbohydrate metabolic process; lysosome organization; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_08930,3.026230086108611,FUN_038392-T1,Peve_00000048,Pocillopora_meandrina_HIv1___RNAseq.g28264.t1,three_way,76.04899999999999,FUN_038392-T1,P16065,,,,,36.6,998.0,4.3999999999999996e-160,567.0,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_01366,3.0219702883351127,FUN_005313-T1,Peve_00003312,Pocillopora_meandrina_HIv1___RNAseq.g8174.t1,three_way,94.14516666666668,FUN_005313-T1,Q04727,TLE4_HUMAN,,Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4),Homo sapiens (Human),84.8,356.0,3.9e-180,632.1,sp|Q04727|TLE4_HUMAN Transducin-like enhancer protein 4 OS=Homo sapiens OX=9606 GN=TLE4 PE=1 SV=3,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0090090; GO:0140297; GO:1990830; GO:1990907,cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055],beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_03546,3.0195547770731963,FUN_014673-T1,Peve_00013033,Pocillopora_meandrina_HIv1___RNAseq.g22680.t1,three_way,77.56683333333334,FUN_014673-T1,Q96AY4,TTC28_HUMAN,,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),Homo sapiens (Human),44.3,828.0,5.7e-171,604.4,sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4,GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301,cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922],kinase binding [GO:0019900],GO:0005815,microtubule organizing center
OG_01156,3.013847886703042,FUN_004767-T1,Peve_00007781,Pocillopora_meandrina_HIv1___RNAseq.g6697.t1,three_way,76.52799999999999,FUN_004767-T1,O57457,,,,,44.1,474.0,3.5e-96,354.4,sp|O57457|E41LA_DANRE Band 4.1-like protein 4 OS=Danio rerio OX=7955 GN=epb41l4a PE=2 SV=1,,,,,,
